Cargando…

Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)

OBJECTIVE: To compare the differences in the serum principal components in ulcerative colitis- (UC-) induced rats, treated with compound Sophora decoction, matrine, oxymatrine monomer mixture, and indirubin monomer, and to provide a modern scientific basis for elucidating the clinical efficacy of co...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wanjin, Zhang, Junjie, Zhou, Conghui, Yan, Bin, Cai, Quan, He, Hongxia, Duan, Xueyun, Fan, Heng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545453/
https://www.ncbi.nlm.nih.gov/pubmed/33062021
http://dx.doi.org/10.1155/2020/7518479
_version_ 1783592037087444992
author Sun, Wanjin
Zhang, Junjie
Zhou, Conghui
Yan, Bin
Cai, Quan
He, Hongxia
Duan, Xueyun
Fan, Heng
author_facet Sun, Wanjin
Zhang, Junjie
Zhou, Conghui
Yan, Bin
Cai, Quan
He, Hongxia
Duan, Xueyun
Fan, Heng
author_sort Sun, Wanjin
collection PubMed
description OBJECTIVE: To compare the differences in the serum principal components in ulcerative colitis- (UC-) induced rats, treated with compound Sophora decoction, matrine, oxymatrine monomer mixture, and indirubin monomer, and to provide a modern scientific basis for elucidating the clinical efficacy of compound Sophora decoction for the treatment of UC. METHODS: The serum samples of rats from each group were obtained after drug administration, and the serum principal components of each group were analyzed by high-resolution mass spectrometry. Agilent Eclipse XDB C18 chromatographic column (100 mm × 2.1 mm, 3.5 m) was used for separation. The mobile phase was water (A) and methanol (B) (0.1% formic acid) gradient elution, 0–3 min (B: 20%–40%), 3–10 min (B: 40%–54%), 10–25 min (B: 54%), 25–35 min (B: 54%–70%), 35–45 min (B: 70%–80%), 45–50 min (B: 80%), 50–60 min (B: 80%–100%), 70–72 min (B: 100%–20%), and 72–77 min (B: 20%); flow rate, 300 μL/min; column temperature, 40°C; and injection volume, 10 μL. ESI source was selected and scanned in the positive and negative ion modes. The scanning range was 70–1500 m/z; ion-source gas 1 (GS1): 55 psi; ion-source gas 2 (GS2): 60 psi; CUR: 30 psi; ion-source temperature (TEM): 550°C; ion-source voltage (ISVF) : 5500 V/−4500 V; decluster voltage (DP): 100 V; collision energy (CE): 35 V/−35 V; collision energy gain (CES) : 15 V/−15 V; and data acquisition mode: IDA. After the data from each group were imported into MarkView 1.3, the molecular weights and retention times of different substances were obtained and qualitatively analyzed by ChemSpider and PeakView 2.0. RESULTS: In the negative ion mode, 26 differential compounds were identified in the compound Sophora decoction group (FFKST) compared to the model group (M), and 18 differential compounds were identified in the matrine and oxymatrine group (KST) compared to the model group (M). In the positive ion mode, 11 and 7 differential compounds were identified in the compound Sophora decoction group (FFKST) and the matrine and oxymatrine group (KST) compared to the model group (M), respectively. The responses of all compounds in each group were compared with each other. As the different principal component substances in the indirubin group (DYH) displayed little correlation with other groups, the different components in this group were not researched thoroughly. CONCLUSION: By comparing the differences in the serum principal components from each administration group, we found that the FFKST group exhibited enhanced synthesis of the serum principal components; however, the compound doses of matrine and oxymatrine monomers did not exhibit the same changes in the serum principal components of UC-induced rats. Finally, the traditional Chinese medicine compound is more advantageous than monomers.
format Online
Article
Text
id pubmed-7545453
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-75454532020-10-13 Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS) Sun, Wanjin Zhang, Junjie Zhou, Conghui Yan, Bin Cai, Quan He, Hongxia Duan, Xueyun Fan, Heng Evid Based Complement Alternat Med Research Article OBJECTIVE: To compare the differences in the serum principal components in ulcerative colitis- (UC-) induced rats, treated with compound Sophora decoction, matrine, oxymatrine monomer mixture, and indirubin monomer, and to provide a modern scientific basis for elucidating the clinical efficacy of compound Sophora decoction for the treatment of UC. METHODS: The serum samples of rats from each group were obtained after drug administration, and the serum principal components of each group were analyzed by high-resolution mass spectrometry. Agilent Eclipse XDB C18 chromatographic column (100 mm × 2.1 mm, 3.5 m) was used for separation. The mobile phase was water (A) and methanol (B) (0.1% formic acid) gradient elution, 0–3 min (B: 20%–40%), 3–10 min (B: 40%–54%), 10–25 min (B: 54%), 25–35 min (B: 54%–70%), 35–45 min (B: 70%–80%), 45–50 min (B: 80%), 50–60 min (B: 80%–100%), 70–72 min (B: 100%–20%), and 72–77 min (B: 20%); flow rate, 300 μL/min; column temperature, 40°C; and injection volume, 10 μL. ESI source was selected and scanned in the positive and negative ion modes. The scanning range was 70–1500 m/z; ion-source gas 1 (GS1): 55 psi; ion-source gas 2 (GS2): 60 psi; CUR: 30 psi; ion-source temperature (TEM): 550°C; ion-source voltage (ISVF) : 5500 V/−4500 V; decluster voltage (DP): 100 V; collision energy (CE): 35 V/−35 V; collision energy gain (CES) : 15 V/−15 V; and data acquisition mode: IDA. After the data from each group were imported into MarkView 1.3, the molecular weights and retention times of different substances were obtained and qualitatively analyzed by ChemSpider and PeakView 2.0. RESULTS: In the negative ion mode, 26 differential compounds were identified in the compound Sophora decoction group (FFKST) compared to the model group (M), and 18 differential compounds were identified in the matrine and oxymatrine group (KST) compared to the model group (M). In the positive ion mode, 11 and 7 differential compounds were identified in the compound Sophora decoction group (FFKST) and the matrine and oxymatrine group (KST) compared to the model group (M), respectively. The responses of all compounds in each group were compared with each other. As the different principal component substances in the indirubin group (DYH) displayed little correlation with other groups, the different components in this group were not researched thoroughly. CONCLUSION: By comparing the differences in the serum principal components from each administration group, we found that the FFKST group exhibited enhanced synthesis of the serum principal components; however, the compound doses of matrine and oxymatrine monomers did not exhibit the same changes in the serum principal components of UC-induced rats. Finally, the traditional Chinese medicine compound is more advantageous than monomers. Hindawi 2020-09-30 /pmc/articles/PMC7545453/ /pubmed/33062021 http://dx.doi.org/10.1155/2020/7518479 Text en Copyright © 2020 Wanjin Sun et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Sun, Wanjin
Zhang, Junjie
Zhou, Conghui
Yan, Bin
Cai, Quan
He, Hongxia
Duan, Xueyun
Fan, Heng
Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title_full Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title_fullStr Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title_full_unstemmed Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title_short Differential Analysis of Serum Principal Components Treated with Compound Sophora Decoction and Related Compounds Based on High-Resolution Mass Spectrometry (HRMS)
title_sort differential analysis of serum principal components treated with compound sophora decoction and related compounds based on high-resolution mass spectrometry (hrms)
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545453/
https://www.ncbi.nlm.nih.gov/pubmed/33062021
http://dx.doi.org/10.1155/2020/7518479
work_keys_str_mv AT sunwanjin differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT zhangjunjie differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT zhouconghui differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT yanbin differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT caiquan differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT hehongxia differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT duanxueyun differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms
AT fanheng differentialanalysisofserumprincipalcomponentstreatedwithcompoundsophoradecoctionandrelatedcompoundsbasedonhighresolutionmassspectrometryhrms